Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 13, 2020
Total Value: $1.586B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | Karuna Therapeutics, Inc. | 1,885,602 | $210M | 13.2% | $111.46 | $24.60 | — | COMM | 48576A100 |
| ASND | Ascendis Pharma A/S | 1,109,874 | $164M | 10.3% | $147.90 | $69.98 | — | ADR | 04351P101 |
| NTRA | Natera | 3,100,560 | $155M | 9.7% | $49.86 * | $9.81 | +309.3% | COMM | 632307104 |
| — | Y-mAbs Therapeutics, Inc | 2,194,278 | $94.79M | 6.0% | $43.20 | $26.75 | — | COMM | 984241109 |
| — | Principia Biopharma | 1,417,258 | $84.74M | 5.3% | $59.79 | $28.92 | — | COMM | 74257L108 |
| — | Nextcure, Inc | 2,671,856 | $57.28M | 3.6% | $21.44 | $17.30 | — | COMM | 65343E108 |
| — | Amgen Inc | 168,500 | $39.74M | 2.5% | $235.86 | — | — | Put | 031162950 |
| UTHR | United Therapeutics Corp | 304,562 | $36.85M | 2.3% | $121.00 * | $90.13 | +24.8% | COMM | 91307C102 |
| — | Amarin | 5,208,305 | $36.04M | 2.3% | $6.92 | $7.81 | — | ADR | 023111206 |
| MRK | Merck & Co Inc | 451,178 | $34.89M | 2.2% | $77.33 * | $66.37 | -5.3% | COMM | 58933Y105 |
| CHRS | Coherus BioSciences | 1,933,221 | $34.53M | 2.2% | $17.86 * | $10.94 | +54.7% | COMM | 19249H103 |
| — | Akouos, Inc | 1,515,073 | $34.09M | 2.1% | $22.50 | $22.50 | — | ADR | 00973J101 |
| GILD | Gilead Sciences Inc | 403,494 | $31.05M | 2.0% | $76.94 * | $61.47 | 0.0% | COMM | 375558103 |
| — | ObsEva SA | 4,749,623 | $27.98M | 1.8% | $5.89 | $13.49 | — | COMM | H5861P103 |
| JAZZ | Jazz Pharmaceuticals PLC | 243,353 | $26.85M | 1.7% | $110.34 | $110.58 | 0.0% | COMM | G50871105 |
| ABBV | Abbvie Inc | 251,959 | $24.74M | 1.6% | $98.18 * | $69.84 | +0.9% | COMM | 00287Y109 |
| LLY | Eli Lilly & Co | 148,900 | $24.45M | 1.5% | $164.18 * | $143.90 | 0.0% | COMM | 532457108 |
| PTCT | PTC Therapeutics Inc | 438,270 | $22.24M | 1.4% | $50.74 * | $43.59 | +12.7% | COMM | 69366J200 |
| — | Alnylam Pharmaceuticals Inc | 150,000 | $22.22M | 1.4% | $148.11 | — | — | Call | 02043Q907 |
| GRTX | Galera Therapeutics, Inc | 3,083,712 | $22.02M | 1.4% | $7.14 * | $12.19 | -12.9% | COMM | 36338D108 |
| — | Merus N.V. | 1,311,039 | $21.09M | 1.3% | $16.09 | $18.53 | — | COMM | N5749R100 |
| — | Acceleron Pharma Inc | 217,390 | $20.71M | 1.3% | $95.27 | $57.73 | — | COMM | 00434H108 |
| — | Kiniksa Pharmaceuticals, Ltd | 809,803 | $20.63M | 1.3% | $25.48 | $17.35 | — | COMM CL A | G5269C101 |
| — | SPDR Ser Tr | 150,000 | $16.79M | 1.1% | $111.95 | — | — | Put | 78464A950 |
| — | SPDR Ser Tr | 150,000 | $15.01M | 0.9% | $100.07 | — | — | Put | 81369Y959 |
| — | Horizon Therapeutics PLC | 252,958 | $14.06M | 0.9% | $55.58 | $55.58 | — | COMM | G46188101 |
| TGTX | TG Therapeutics Inc | 696,390 | $13.57M | 0.9% | $19.48 * | $12.49 | +28.9% | COMM | 88322Q108 |
| INSM | Insmed Inc | 483,967 | $13.33M | 0.8% | $27.54 * | $23.71 | 0.0% | COMM | 457669307 |
| — | Nucana Biomed Ltd | 2,400,000 | $12.98M | 0.8% | $5.41 | $5.41 | — | Ordinary Shares | GBOOBYWYV |
| PBYI | Puma Biotechnology Inc | 1,197,630 | $12.49M | 0.8% | $10.43 | $10.01 | +3.4% | COMM | 74587V107 |
| — | Nucana Biomed Ltd | 2,266,666 | $12.26M | 0.8% | $5.41 | $15.80 | — | ADR | 67022C106 |
| SUPN | Supernus Pharmaceuticals Inc | 478,329 | $11.36M | 0.7% | $23.75 * | $22.09 | 0.0% | COMM | 868459108 |
| — | Zymeworks Inc | 299,734 | $10.81M | 0.7% | $36.07 | $33.72 | — | COMM | 98985W102 |
| — | MyoKardia Inc | 111,810 | $10.8M | 0.7% | $96.62 | $60.83 | — | COMM | 62857M105 |
| MIRM | Mirum Pharmaceuticals Inc | 541,701 | $10.54M | 0.7% | $19.46 * | $16.48 | +1.4% | COMM | 604749101 |
| — | iShares Tr | 70,000 | $10.02M | 0.6% | $143.19 | — | — | Put | 464287955 |
| KURA | Kura Oncology Inc | 610,979 | $9.959M | 0.6% | $16.30 * | $14.42 | 0.0% | COMM | 50127T109 |
| AKBA | Akebia Therapeutics Inc | 681,892 | $9.261M | 0.6% | $13.58 * | $10.35 | 0.0% | COMM | 00972D105 |
| — | Chiasma | 1,630,221 | $8.771M | 0.6% | $5.38 | $1.49 | — | COMM | 16706W102 |
| — | Kadmon Holdings Inc | 1,530,864 | $7.838M | 0.5% | $5.12 | $2.74 | — | COMM | 48283N106 |
| BMRN | Biomarin Pharmaceutical Inc | 62,897 | $7.757M | 0.5% | $123.33 * | $77.86 | +27.7% | COMM | 09061G101 |
| — | Invesco QQQ Trust | 30,000 | $7.428M | 0.5% | $247.60 | — | — | Put | 46090E953 |
| — | Blueprint Medicines Corp | 94,891 | $7.401M | 0.5% | $77.99 | $65.02 | — | COMM | 09627Y109 |
| AXSM | Axsome Therapeutics Inc | 86,978 | $7.156M | 0.5% | $82.27 * | $80.76 | -4.7% | COMM | 05464T104 |
| LQDA | Liquidia Technologies Inc | 800,000 | $6.736M | 0.4% | $8.42 * | $7.59 | 0.0% | COMM | 53635D202 |
| BCRX | BioCryst Pharmaceuticals Inc | 1,357,848 | $6.47M | 0.4% | $4.76 * | $3.54 | +12.9% | COMM | 09058V103 |
| — | Applied Genetic Technologies Corp | 1,145,254 | $6.345M | 0.4% | $5.54 | $3.44 | — | COMM | 03820J100 |
| — | Constellation Pharmaceuticals Inc | 207,087 | $6.223M | 0.4% | $30.05 | $30.05 | — | COMM | 210373106 |
| — | Intra-Cellular Therapies Inc | 241,908 | $6.209M | 0.4% | $25.67 | $23.46 | — | COMM | 46116X101 |
| — | Otonomy Inc | 1,651,411 | $5.978M | 0.4% | $3.62 | $2.92 | — | COMM | 68906L105 |
| PTGX | Protagonist Therapeutics Inc | 326,064 | $5.758M | 0.4% | $17.66 * | $12.55 | 0.0% | COMM | 74366E102 |
| — | Pfizer Inc | 175,000 | $5.723M | 0.4% | $32.70 | — | — | Call | 717081903 |
| — | Intra-Cellular Therapies Inc | 220,000 | $5.647M | 0.4% | $25.67 | — | — | Put | 46116X951 |
| — | ChemoCentryx Inc | 96,916 | $5.577M | 0.4% | $57.54 | $45.16 | — | COMM | 16383L106 |
| — | Calithera Biosciences Inc | 1,040,399 | $5.493M | 0.3% | $5.28 | $4.49 | — | COMM | 13089P101 |
| — | Kala Pharmaceuticals Inc | 506,647 | $5.325M | 0.3% | $10.51 | $6.47 | — | COMM | 483119103 |
| — | Homology Medicines Inc | 344,579 | $5.234M | 0.3% | $15.19 | $15.90 | — | COMM | 438083107 |
| CYTK | Cytokinetics Inc | 160,217 | $3.776M | 0.2% | $23.57 * | $18.75 | 0.0% | COMM | 23282W605 |
| — | Entasis Therapeutics Holdings Inc. | 1,180,178 | $3.493M | 0.2% | $2.96 | $10.88 | — | COMM | 293614103 |
| — | Mersana Therapeutics Inc | 137,966 | $3.228M | 0.2% | $23.40 | $5.83 | — | COMM | 59045L106 |
| ACRS | Aclaris Therapeutics | 1,911,573 | $3.097M | 0.2% | $1.62 * | $19.07 | -93.0% | COMM | 00461U105 |
| — | PTC Therapeutics Inc | 60,000 | $3.044M | 0.2% | $50.73 | — | — | Call | 69366J900 |
| — | Novocure Ltd | 50,000 | $2.965M | 0.2% | $59.30 | — | — | Call | G6674U908 |
| — | Reata Pharmaceuticals Inc | 13,035 | $2.034M | 0.1% | $156.04 | $156.04 | — | COMM | 75615P103 |
| APLS | Apellis Pharmaceuticals, Inc | 49,580 | $1.619M | 0.1% | $32.65 | $19.65 | +63.4% | COMM | 03753U106 |
| CGEN | Compugen Ltd | 103,587 | $1.557M | 0.1% | $15.03 * | $7.86 | +71.8% | COMM | M25722105 |
| SNDX | Syndax Pharmaceuticals Inc | 91,964 | $1.363M | 0.1% | $14.82 * | $15.23 | 0.0% | COMM | 87164F105 |
| — | Menlo Therapeutics Inc | 725,571 | $1.256M | 0.1% | $1.73 | $2.52 | — | COMM | 586858102 |
| NTLA | Intellia Therapeutics Inc | 57,500 | $1.209M | 0.1% | $21.03 * | $16.99 | 0.0% | COMM | 45826J105 |
| — | Synlogic Inc. | 574,972 | $1.167M | 0.1% | $2.03 | $9.38 | — | COMM | 87166L100 |
| IMVT | Immunovant Inc | 40,513 | $987K | 0.1% | $24.36 * | $21.43 | 0.0% | COMM | 45258J102 |
| — | Mirati Therapeutics Inc | 8,072 | $922K | 0.1% | $114.22 | $114.22 | — | COMM | 60468T105 |
| — | Arena Pharmaceuticals Inc | 13,929 | $877K | 0.1% | $62.96 | $62.96 | — | COMM | 040047607 |
| — | Rigel Pharmaceuticals Inc | 339,695 | $622K | 0.0% | $1.83 | $1.56 | — | COMM | 766559603 |
| ORIC | Oric Pharmaceuticals Inc | 17,369 | $585K | 0.0% | $33.68 * | $31.92 | 0.0% | COMM | 68622P109 |
| PDSB | PDS Biotechnology Corporation | 142,635 | $287K | 0.0% | $2.01 * | $8.36 | -86.7% | COMM | 70465T107 |